Basics BioXcel Therapeutics, Inc. IPO Date: March 5, 2018 Sector: Healthcare Industry: Biotech Market Cap: $7.99M Activated in VL: True Average Daily Range Avg Daily Range: $0.63 | 4.13% Avg Daily Range (30 D): $0.08 | 4.94% Avg Daily Range (90 D): $0.12 | 6.36% Institutional Daily Volume Avg Daily Volume: .68M Avg Daily Volume (30 D): .23M Avg Daily Volume (90 D): 2.63M Trade Size Avg Trade Size (Sh.): 128 Avg Trade Size (Sh.) (30 D): 183 Avg Trade Size (Sh.) (90 D): 232 Institutional Trades Total Inst.Trades: 897 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.6M Avg Inst. Trade (90 D): $.6M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.56M Avg Closing Trade (30 D): $2.34M Avg Closing Trade (90 D): $2.34M Avg Closing Volume: 3.96K     News May 27, 2025 @ 11:00 AM BioXcel Therapeutics Granted Extension to Regain C... Source: N/A Apr 28, 2025 @ 5:00 PM Evolving Landscape of Mental Health Segment: Key M... Source: Delveinsight Mar 11, 2025 @ 11:00 AM BioXcel Therapeutics Strengthens Cash Position to ... Source: Bioxcel Therapeutics, Inc. Nov 21, 2024 @ 9:47 PM BioXcel Therapeutics Announces Proposed Public Off... Source: Globe Newswire Nov 21, 2024 @ 9:47 PM BioXcel Therapeutics Announces Proposed Public Off... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-24.25 $-1.5 $-22.22 Diluted EPS $-24.25 $-1.5 $-22.22 Revenue $ 1.85M $ .17M $ .37M Gross Profit $ -.23M $ .15M $ -.47M Net Income / Loss $ -40.06M $ -7.25M $ -10.86M Operating Income / Loss $ -53.18M $ -10.1M $ -10.49M Cost of Revenue $ 2.08M $ .01M $ .83M Net Cash Flow $ M $ M $ M PE Ratio     Splits Feb 10, 2025:   1:16